Ovagen 20 mg
Main Image

Ovagen 20 mg

Steroids Dragon Pharma Peptide

$26.40

Ovagen 20 mg – Peptide Hubs

Ovagen is a liver-targeted peptide complex developed to support hepatocyte function, DNA repair, and systemic detoxification pathways. As a cytomedin, Ovagen is derived from liver tissue and consists of short peptides designed to regulate gene expression in liver cells, protect against hepatotoxins, and enhance overall liver regeneration. Peptide Hubs offers Ovagen 20 mg in high-purity lyophilized form for scientific research.

Mechanism of Action

Ovagen exerts its effects through selective organotropic action on hepatocytes. It modulates the transcription of genes involved in cell protection, protein synthesis, antioxidant activity, and inflammation reduction. Research suggests it may upregulate detox enzymes while stabilizing DNA and RNA processes in liver cells. According to published Russian data on cytomedins, liver peptides like Ovagen show promise in managing toxic liver damage and oxidative stress. More info can be found in this NIH liver regeneration review.

Key Research Applications

  • Liver regeneration and hepatocyte recovery models
  • DNA repair and gene expression modulation studies
  • Alcohol or drug-induced liver stress research
  • Chronic inflammation and oxidative damage protocols

Ovagen is often stacked with L-Glutathione for antioxidant support, or Humanin to explore mitochondrial-liver interactions. For DNA repair synergy, consider pairing with Livagen. Additionally, FOX04-DRI is frequently studied in parallel to examine aging and senescence in liver cell environments.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Dragon Pharma
Manufacturer: Dragon Pharma
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines</h2> <ul> <li><strong>Dosage:</strong> 20–40 mg per week (e.g. 10 mg 2–4x weekly)</li> <li><strong>Administration:</strong> Subcutaneous or intramuscular (lab-controlled)</li> <li><strong>Duration:</strong> 4–6 weeks in hepatocyte-focused research</li> </ul> <h3>Stacking Recommendations</h3> <ul> <li>L-Glutathione – antioxidant synergy for detox research</li> <li>Humanin – for mitochondrial protective synergy</li> <li>Livagen – for DNA and chromatin repair models</li> <li>FOX04-DRI – in senescence and liver aging protocols</li> </ul> <h3>Legal Disclaimer</h3> <p>Ovagen is not FDA-approved. It is sold for <strong>scientific and research purposes only</strong>. Preclinical studies show no aromatization, androgenic activity, or hepatotoxicity. Always adhere to local guidelines for peptide handling and storage.</p> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Synthetic Tripeptide
Peptide Sequence
Glu-Asp-Leu (EDL)
Peptide Length
3 Amino-Acid Residues
Terminal Form
H-Glu-Asp-Leu-OH
Molecular Formula
C₁₅H₂₅N₃O₈
Molecular Weight
375.37 g/mol
PubChem CID
444128
Sequence Code
EDL
Research Status
Experimental / Preclinical

Chat on WhatsApp